Cite
MLA Citation
Ana Oaknin et al.. “2022-LBA-325-ESGO Patients with newly diagnosed ovarian cancer treated with maintenance rucaparib: exploratory biomarker analysis from the phase 3 ATHENA-MONO study (GOG-3020/ENGOT-ov45; NCT03522246).” International journal of gynecological cancer, vol. 32, n.d., p. A472. http://access.bl.uk/ark:/81055/vdc_100168596713.0x00003b